Morgan Stanley $MS Shares Sold by Ilmarinen Mutual Pension Insurance Co

Ilmarinen Mutual Pension Insurance Co lowered its stake in Morgan Stanley (NYSE:MSFree Report) by 31.3% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 153,984 shares of the financial services provider’s stock after selling 70,000 shares during the quarter. Ilmarinen Mutual Pension Insurance Co’s holdings in Morgan Stanley were worth $27,337,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the stock. CBIZ Investment Advisory Services LLC lifted its position in Morgan Stanley by 12.3% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 502 shares of the financial services provider’s stock valued at $89,000 after buying an additional 55 shares during the last quarter. Powers Advisory Group LLC lifted its position in Morgan Stanley by 4.0% in the fourth quarter. Powers Advisory Group LLC now owns 1,443 shares of the financial services provider’s stock valued at $256,000 after buying an additional 56 shares during the last quarter. Central Bank & Trust Co. lifted its position in Morgan Stanley by 3.4% in the fourth quarter. Central Bank & Trust Co. now owns 1,767 shares of the financial services provider’s stock valued at $314,000 after buying an additional 58 shares during the last quarter. Howard Financial Services LTD. lifted its position in Morgan Stanley by 1.6% in the fourth quarter. Howard Financial Services LTD. now owns 3,579 shares of the financial services provider’s stock valued at $635,000 after buying an additional 58 shares during the last quarter. Finally, Balboa Wealth Partners lifted its position in Morgan Stanley by 1.9% in the fourth quarter. Balboa Wealth Partners now owns 3,181 shares of the financial services provider’s stock valued at $565,000 after buying an additional 59 shares during the last quarter. Institutional investors and hedge funds own 84.19% of the company’s stock.

Morgan Stanley Stock Performance

Shares of Morgan Stanley stock opened at $203.90 on Friday. The firm has a market capitalization of $321.60 billion, a P/E ratio of 18.47, a P/E/G ratio of 1.51 and a beta of 1.22. Morgan Stanley has a 52 week low of $126.35 and a 52 week high of $204.38. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 3.52. The firm’s 50 day moving average is $182.79 and its two-hundred day moving average is $177.18.

Morgan Stanley (NYSE:MSGet Free Report) last announced its earnings results on Wednesday, April 15th. The financial services provider reported $3.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.02 by $0.41. The business had revenue of $20.58 billion for the quarter, compared to analyst estimates of $19.23 billion. Morgan Stanley had a net margin of 14.65% and a return on equity of 17.70%. The company’s revenue for the quarter was up 16.0% compared to the same quarter last year. During the same period last year, the firm posted $2.60 earnings per share. Research analysts forecast that Morgan Stanley will post 11.85 EPS for the current fiscal year.

Morgan Stanley Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Thursday, April 30th were given a dividend of $1.00 per share. The ex-dividend date was Thursday, April 30th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.0%. Morgan Stanley’s dividend payout ratio (DPR) is 36.23%.

Key Stories Impacting Morgan Stanley

Here are the key news stories impacting Morgan Stanley this week:

  • Positive Sentiment: Morgan Stanley continued to benefit from strong recent earnings, with the company having recently beaten consensus on both EPS and revenue, reinforcing confidence in its operating performance.
  • Positive Sentiment: Recent commentary highlighted “record revenue” and rising dividends, which can help attract income-focused investors and support the stock’s valuation. Record Revenue, Rising Dividends—So Why Aren’t Analysts Saying Buy? (MS)
  • Positive Sentiment: Analyst coverage remains constructive overall, including multiple buy-equivalent ratings and a recent price target of $610 from Morgan Stanley analyst Manan Gosalia on Broadcom-related coverage, which reflects the firm’s continued visibility across key growth themes.
  • Neutral Sentiment: Some articles mention Morgan Stanley in connection with broader market calls and conference sponsorships, which are not direct catalysts for MS shares but keep the firm in the headlines.

Insider Transactions at Morgan Stanley

In other news, insider Daniel A. Simkowitz sold 14,690 shares of the firm’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $189.24, for a total transaction of $2,779,935.60. Following the transaction, the insider directly owned 365,802 shares in the company, valued at approximately $69,224,370.48. This trade represents a 3.86% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Eric F. Grossman sold 11,118 shares of the stock in a transaction on Monday, April 20th. The stock was sold at an average price of $190.75, for a total value of $2,120,758.50. Following the sale, the insider directly owned 169,403 shares of the company’s stock, valued at approximately $32,313,622.25. This represents a 6.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 77,476 shares of company stock worth $14,644,762. Insiders own 0.17% of the company’s stock.

Analyst Ratings Changes

MS has been the topic of a number of recent analyst reports. Jefferies Financial Group cut shares of Morgan Stanley from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 9th. Citigroup increased their price target on shares of Morgan Stanley from $170.00 to $194.00 and gave the stock a “neutral” rating in a research report on Friday, May 8th. Dbs Bank increased their price target on shares of Morgan Stanley from $185.00 to $220.00 in a research report on Thursday, May 7th. Wells Fargo & Company increased their price target on shares of Morgan Stanley from $189.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 16th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a $207.00 price target on shares of Morgan Stanley in a research report on Thursday, April 16th. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $205.95.

Check Out Our Latest Stock Analysis on Morgan Stanley

Morgan Stanley Company Profile

(Free Report)

Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.

The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.

Recommended Stories

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MSFree Report).

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.